- Home
- MTVA vs JVA Comparison
MTVA vs JVA Comparison
Compare MTVA & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- JVA
- Stock Information
- Founded
- MTVA 2014
- JVA 1971
- Country
- MTVA United States
- JVA United States
- Employees
- MTVA N/A
- JVA N/A
- Industry
- MTVA
- JVA Packaged Foods
- Sector
- MTVA
- JVA Consumer Staples
- Exchange
- MTVA NYSE
- JVA Nasdaq
- Market Cap
- MTVA 18.9M
- JVA 22.5M
- IPO Year
- MTVA N/A
- JVA 2005
- Fundamental
- Price
- MTVA $1.95
- JVA $3.66
- Analyst Decision
- MTVA Strong Buy
- JVA
- Analyst Count
- MTVA 1
- JVA 0
- Target Price
- MTVA $12.00
- JVA N/A
- AVG Volume (30 Days)
- MTVA 337.7K
- JVA 90.5K
- Earning Date
- MTVA 11-07-2024
- JVA 02-07-2025
- Dividend Yield
- MTVA N/A
- JVA N/A
- EPS Growth
- MTVA N/A
- JVA N/A
- EPS
- MTVA N/A
- JVA 0.20
- Revenue
- MTVA N/A
- JVA $76,111,698.00
- Revenue This Year
- MTVA N/A
- JVA N/A
- Revenue Next Year
- MTVA N/A
- JVA N/A
- P/E Ratio
- MTVA N/A
- JVA $18.58
- Revenue Growth
- MTVA N/A
- JVA 17.27
- 52 Week Low
- MTVA $1.51
- JVA $1.01
- 52 Week High
- MTVA $6.75
- JVA $4.66
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- JVA 47.68
- Support Level
- MTVA N/A
- JVA $3.32
- Resistance Level
- MTVA N/A
- JVA $3.75
- Average True Range (ATR)
- MTVA 0.00
- JVA 0.26
- MACD
- MTVA 0.00
- JVA -0.02
- Stochastic Oscillator
- MTVA 0.00
- JVA 40.96
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.